Preclinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026

Key Benefits of the Report

This must-have industry resource provides exclusive insights to help companies assess, structure, and negotiate their own preclinical-stage partnerships. Key benefits include:

✔ Time-Saving Market Intelligence – Eliminate the need for manual research with ready-to-use insights on industry trends and deal structures.

✔ Unmatched Financial Data Access – Gain exclusive insight into headline values, upfront payments, milestone structures, and royalty terms to optimize negotiations.

✔ Comprehensive Deal Database – Access over 1,750 preclinical-stage agreements, including contract documents where available.

✔ Deep-Dive into Industry Leaders – Analyze actual preclinical-stage deals entered into by the top 25 global pharma and biotech companies, alongside emerging players.

✔ Strategic Case Studies & Deal Analysis – Examine real-world deal structures and negotiation strategies to enhance your own business development approach.

✔ High-Value Deal Identification – Pinpoint the most lucrative preclinical-stage deals signed since 2020, gaining insight into premium industry transactions.

✔ Profile the Most Active Dealmakers – Identify key players driving preclinical-stage collaborations, ensuring you engage with the right partners.

✔ Full Deal Listings & Categorization – Navigate a complete A-Z listing of preclinical-stage agreements, categorized by company, development phase, deal type, therapeutic area, and technology focus.

✔ Negotiate with Confidence – Understand the key terms and conditions agreed upon in previous deals, helping you structure optimal agreements.

✔ Robust Due Diligence Support – Conduct data-backed assessments to determine the viability and competitiveness of your proposed deal terms.

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Why do companies partner preclinical stage compounds?
2.1. Introduction
2.2. The role of preclinical stage partnering
2.2.1. In-licensing at preclinical stage
2.2.2. Out-licensing at preclinical stage
2.3. Difference between discovery, preclinical and clinical stage deals
2.4. Reasons for entering into preclinical stage partnering deals
2.4.1. Licensors reasons for entering preclinical stage deals
2.4.2. Licensees reasons for entering preclinical stage deals
2.5. The future of preclinical stage partnering deals

Chapter 3 – Preclinical stage deal strategies and structure
3.1. Introduction
3.2. At what stage do companies partner?
3.2.1. Partnering early in pharmaceutical / biotech
3.2.1.1. Discovery and preclinical stage partnering case studies
3.2.1.1.a. Case study 1
3.2.1.1.b. Case study 2
3.2.1.1.c. Case study 3
3.2.1.1.d. Case study 4
3.2.2. Partnering later in pharmaceutical/biotech
3.2.2.1. Clinical stage partnering case studies
3.2.2.1.a. Case study 5
3.2.2.1.b. Case study 6
3.2.2.1.c. Case study 7
3.2.2.1.d. Case study 8
3.3. Early and later stage partnering – a risk/cost comparison
3.4. What do companies spend on preclinical stage partnering?
3.5. Pure versus multi-component partnering deals
3.6. Pure licensing agreement structure
3.6.1. Example pure preclinical stage licensing agreements
3.6.1.a. Case study 9
3.6.1.b. Case study 10
3.7. Multicomponent preclinical stage partnering agreements
3.7.1. Example multicomponent preclinical stage clauses
3.7.1.a. Case study 11
3.7.1.b. Case study 12

Chapter 4 – Preclinical stage partnering payment strategies
4.1. Introduction
4.2. Preclinical stage payment strategies
4.3. Payment options
4.3.1. Headline values
4.3.2. Upfront payments
4.3.2.1. Conditionality of upfront payments
4.3.3. Loans
4.3.4. Convertible loans
4.3.5. Equity
4.3.6. R&D funding
4.3.7. Licensing fees
4.3.8. Milestone payments
4.3.9. Royalty payments
4.3.9.1. Issues affecting royalty rates
4.3.9.2. Royalties on combination products
4.3.9.2.a. Case study 13
4.3.9.3. Guaranteed minimum/maximum annual payments
4.3.9.4. Royalty stacking
4.3.9.5. Royalties and supply/purchase contracts
4.3.10. Quids
4.3.11. Option payments

Chapter 5 – Trends in preclinical stage deal making
5.1. Introduction
5.2. Preclinical stage partnering over the year
5.2.1. Attributes of preclinical deals
5.3. Preclinical stage partnering by deal type
5.4. Preclinical stage partnering by disease type
5.5. Partnering by preclinical stage technology type
5.6. Preclinical stage partnering by most active company

Chapter 6 – Payment terms for preclinical stage partnering
6.1. Introduction
6.2. Guidelines for preclinical stage payment terms
6.2.1. Upfront payments
6.2.2. Milestone payments
6.2.3. Royalty payments
6.3. Preclinical stage payment terms – deal data analysis
6.3.1. Public data
6.3.2. Survey data
6.4. Payment terms analysis
6.4.1. Preclinical stage headline values
6.4.2. Preclinical stage deal upfront payments
6.4.3. Preclinical stage deal milestone payments
6.4.4. Preclinical stage royalty rates

Chapter 7 – Leading preclinical stage deals
7.1. Introduction
7.2. Top preclinical stage deals by value

Chapter 8 – Top 25 most active preclinical stage dealmakers
8.1. Introduction
8.2. Top 25 most active preclinical stage dealmakers

Chapter 9 – Preclinical stage partnering contracts directory
9.1. Introduction
9.2. Preclinical stage deals with contracts

Chapter 10 – Preclinical stage deal making by development stage
10.1. Introduction
10.2. Deals by preclinical stage

Appendices
Appendix 1 – Preclinical stage dealmaking by companies A-Z
Appendix 2 – Preclinical stage dealmaking by industry sector
Appendix 3 – Preclinical stage dealmaking by stage of development
Appendix 4 – Preclinical stage dealmaking by therapy area
Appendix 5 – Preclinical stage dealmaking by technology type

About Biopharma Research Ltd
Current Partnering
Current Agreements
Recent titles from Current Partnering

Table of figures
Figure 1: Definition of discovery, preclinical and clinical phases in dealmaking
Figure 2: Components of the pure licensing deal structure
Figure 3: Payment options for preclinical stage partnering deals
Figure 4: Issues affecting royalty rates
Figure 5: Preclinical stage partnering frequency
Figure 6: Preclinical stage partnering by deal type
Figure 7: Preclinical stage partnering by disease type
Figure 8: Preclinical stage partnering by technology type
Figure 9: Top 25 most active preclinical stage dealmakers
Figure 10: Review of upfront payments for preclinical stage deals
Figure 11: Review of milestone payments for preclinical stage deals
Figure 12: Review of royalty payments for preclinical stage deals
Figure 13: Preclinical stage deals with a headline value
Figure 14: Preclinical stage deals with an upfront value
Figure 15: Preclinical stage deals with a milestone value
Figure 16: Preclinical stage deals with a royalty rate value
Figure 17: Top preclinical stage deals by value
Figure 18: Most active preclinical stage dealmakers

Pricing options

• $4,995: single-user
• $6,995: 2-5 users
• $8,995: Corporate (unencrypted PDF)

 

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

Sales Support

If you have any questions about your report, we will do our best to resolve your query. Contact us direct.

Total Trust

Current Partnering is part of Biopharma Research Ltd., based in County Durham, United Kingdom. We have been trading successfully online since 2012 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

2seventy bio, 3B Pharmaceuticals, 3D Medicines, 3rd People’s Hospital of Shenzhen, 4basebio Discovery, 4C Biomed, 4E Therapeutics, 4P-Pharma, 7 Hills Pharma, 9 Meters Biopharma, 10X Genomics, 23andMe, 180 Life Sciences, A*STAR Agency for Science, Technology and Research, A2 Biotherapeutics, Aadi Bioscience, Aarhus University, Aarvik Therapeutics, Abbisko Therapeutics, Abbvie, AbCellera Biologics, Abdul Latif Jameel Health, Abeona Therapeutics, Abera Bioscience, AbFero Pharmaceuticals, ABL Bio, Abound Bio, Abpro, AbSci, ABT Innovations, ABVC BioPharma, Abzena, Academy of Military Medical Sciences (China), ACADIA Pharmaceuticals, Accure Therapeutics, ACEA Therapeutics, Acepodia, Aceragen, Acer Therapeutics, Ache, Achieve Life Science, Aclipse Therapeutics, Actelion, Actimed Therapeutics, Actinium Pharmaceuticals, Acuitas Therapeutics, Acumen Pharmaceuticals, AcuraStem, Adalvo, AdaptVac, Adcendo, ADC Therapeutics, Addex Therapeutics, Adge Pharmaceuticals, Adhera Therapeutics, Adjuvance Technologies, Adlai Nortye, Adolore Biotherapeutics, Advaccine Biotechnology, Advanced Biological Laboratories, Advanced Regenerative Manufacturing Institute, Aelis Pharma, Aethon Therapeutics, Affimed Therapeutics, AGC Biologics, Ageless Biotech, Agena Bioscience, Agenus Bio, AgeX Therapeutics, AgomAb Therapeutics, AgonOx, AiCuris, AIkido Pharma, AimedBio, AIM ImmunoTech, Aimmune Therapeutics, Aion Therapeutic, Airway Therapeutics, Akari Therapeutics, AKSO Biopharmaceutical, Akston Biosciences, Albany Molecular Research, Alberta Cell Therapy Manufacturing, Alchemab, Alchemedicine, Aldevron, Alector, Alectos Therapeutics, Aleta Biotherapeutics, Alexander Shulgin Research Institute, Alexion Pharmaceuticals, Algae-C, Algernon Pharmaceuticals, Aligos Therapeutics, Alivexis, Alivio Therapeutics, Allarity Therapeutics, Alliance for Cancer Gene Therapy, Alligator Bioscience, Allist Pharma, Allogene Overland Biopharm, Allogene Therapeutics, Allorion Therapeutics, Alloy Therapeutics, AllStripes, Almac Discovery, Almirall, Alnylam Pharmaceuticals, Alopexx, Alpha Cognition, Alphamab Biopharmaceuticals, Alpha Tau Medical, Alpine Immune Sciences, ALS Association, Altasciences, Alteogen, Altesa Biosciences, Altimmune, Alto Neuroscience, Alveus Therapeutics, Alvotech, Amarna Therapeutics, Ambiopharm, Ambrx, Amerimmune, Amgen, Amicus Therapeutics, AmideBio, Amneal Pharmaceuticals, Amolyt Pharma, Ampio Pharmaceuticals, Amunix, Amygdala Neurosciences, Amyris, AN2 Therapeutics, Anagram Therapeutics, AnaptysBio, Angany, Angelini Pharma, AnHeart Therapeutics, Anima Biotech, Anixa Biosciences, Ankyra Therapeutics, Annovis Bio, Anokion, Anova Enterprises, ANP Technologies, Antengene, Apic Bio, Apmonia Therapeutics, Apollomics, Apollon Formularies, Applied Biology, Applied BioMath, Applied Biomedical Science Institute, Applied DNA Sciences, Applied Genetic Technologies, AprilBio, Aptorum Group, Aqualung Therapeutics, Aquinnah Pharmaceuticals, Aragen Bioscience, Arbor Biosciences, Arbor Biotechnologies, ARC Therapeutics, Arctic Therapeutics, Arctic University of Norway, Arctic Vision, Arcturus Therapeutics, Arcus Biosciences, Arecor, Argenta, argenx, Arizona State University, Arkuda Therapeutics, Armatus Bio, Arovella Therapeutics, Arrevus, ArriVent Biopharma, Arrowhead Pharmaceuticals, ARScience Biotherapeutics, ARTBIO, Artelo Biosciences, ArtemiLife, Artes Biotechnology, Artios Pharma, Artiva Biotherapeutics, Artizan Biosciences, Arvinas, Asahi Kasei, Ascentage Pharma, Asep Medical, Asher Biotherapeutics, Ashvattha Therapeutics, Asimov, Asklepios Biopharmaceutical, Astellas Institute for Regenerative Medicine, Astellas Pharma, Astellas Pharma US, Astellas Venture Management, AstraZeneca, Astria Therapeutics, Astrogen, Asylia Therapeutics, Asymchem Laboratories, Atara Biotherapeutics, Atbtherapeutics, Ateria Health, Athenex, Atreca, Attralus, ATUM, aTyr Pharma, Augmenta, AUM Biosciences, AUM LifeTech, Aurealis Therapeutics, Aurigene Discovery Technologies, Aurinia Pharmaceuticals, Austrian Research Promotion Agency, Autifony Therapeutics, Avania, Avectas, Avenzo Therapeutics, AVEO Oncology, Avery Therapeutics, AviadoBio, Avid Bioservices, AVM Biotechnology, Avrobio, Axelys, Axoltis Pharma, Axovant Gene Therapies, Aytu BioPharma, Azome Therapeutics, Bach Biosciences, Banner MD Anderson Cancer Center, Barer Institute, Barth Syndrome Foundation, Bascom Palmer Eye Institute, Basilea Pharmaceutica, Batavia Biosciences, Bateman Horne Center, Bayer, Baylor College of Medicine, BayMedica, Beam Therapeutics, Be Biopharma, BeiGene, Beijing InnoCare Pharma, Beijing Mabworks Biotech, Beijing Tianshi Tongda Pharmaceuticals Technology, BenchSci, Bend Bioscience, Beroni Group, Be The Match BioTherapies, Beth Israel Deaconess Medical Center, Betta Pharmaceuticals, Bexorg, Beyond Batten Disease Foundation, Bharat Biotech, Bial, Bicycle Therapeutics, Bill and Melinda Gates Foundation, Bio-Sourcing, Bio-Techne, BioAesthetics, BioAge Labs, BioAnalytical Systems, Bioarchitech, BioArctic AB, BioArdis, BioAtla, BioCardia, BioCentriq, BioCina, Biocytogen, Biodesix, Biodextris, BioEleven, Biofabri, Biogen, Biohaven Pharmaceuticals, BioInvent, BioKey, Biolojic Design, BioMarin Pharmaceutical, Biomedical Advanced Research and Development Authority, Biomedical Catalyst Fund (UK), Biomica, Biomunex Pharmaceuticals, Bionaut Labs, Biond Biologics, BiondVax, Bionomics, BioNova Pharmaceuticals, BioNTech, BioNxt Solutions, Bioprojet, Biose Industrie, Biosion, Biosplice, Biotheus, Biotools, BioVaxys, Bioventure MDC, BioVersys, BioVie, BIRAD Research and Development Company, Bird Foundation, Blacksmith Medicines, Blackstone Medical, Blau Pharma, Bloom Science, Bluebird Bio, BlueJay Therapeutics, Blueprint Medicines, BlueRock Therapeutics, Blue Water Vaccines, BlueWillow Biologics, Boehringer Ingelheim, Bohai Biomedical, Bold Therapeutics, Bolt Biotherapeutics, Bone Therapeutics, Boryung Pharmaceutical, BostonGene, Boston Pharmaceuticals, Boston University, Bpifrance, Brenus Pharma, BriaCell Therapeutics, BriaPro Therapeutics, BrickBio, Brickell Biotech, BridgeBio Pharma, Bridge Biotherapeutics, Bridge Medicines, BridGene Biosciences, Brigham and Women's Hospital, BrighGene Biomedical, Bright Peak Therapeutics, Brii Biosciences, Bristol-Myers Squibb, Broad Institute, Brown University, Bugworks, Butantan Institute, C4 Therapeutics, C4X Discovery, Cabaletta Bio, Caeregen Therapeutics, Cajal Neuroscience, Calidi Biotherapeutics, Califia Pharma, California Institute for Biomedical Research, California Institute for Regenerative Medicine, Calithera Biosciences, Calvert Laboratories, Camargo Pharmaceutical Services, Cambrian Biopharma, CAMP4 Therapeutics, Camurus, CANbridge Pharmaceuticals, Cancer Prevention and Research Institute of Texas, Cancer Research Institute, Cancer Research UK, CancerVax, Candel Therapeutics, Candid Therapeutics, Cannabics Pharmaceuticals, Cannex Scientific, Cannomed Medical Cannabis Industries, Cantargia, Cantex Pharmaceuticals, CARB-X, Cardiovascular Solutions of Central Mississippi, Carina Biotech, Caris Life Sciences, Carisma Therapeutics, Carna BioSciences, CaroGen, CARsgen, Cascade Chemistry, Case Western Reserve University, CASI Pharmaceuticals, Catabasis Pharmaceuticals, Catalent, Catamaran Bio, Catholic University Leuven, CB Therapeutics, CDR-Life, Cedars-Sinai Medical Center, Cedilla Therapeutics, Celator, Celest Therapeutics, CellBion, Cellect Biotechnology, Cellevolve Bio, Cellipont Bioservices, Cell Mogrify, Celloram, Cell Point, Celltrion, Cellumed, Cellusion, Celmatix, Celonic, Celularity, Celyn Therapeutics, Centers for Disease Control and Prevention, Centessa Pharmaceuticals, Centivax, Centre for Addiction and Mental Health, Centre for Human Drug Research, Centre for Probe Development and Commercialization, Century Therapeutics, Cerecor, Cerveau Technologies, Charcot-Marie-Tooth Association, Charite Universitatsmedizin Berlin, Charles River Laboratories, Checkpoint Therapeutics, Chemify, Chemomab Therapeutics, Chemveda Life Sciences, Chengdu Baiyu Pharmaceutical, Chi-Med, Chiesi Farmaceutici, Children's Hospital Boston, Chime Biologics, Chimeron Bio, Chinook Therapeutics, Chiome Bioscience, Choroideremia Research Foundation, ChromaDex, Ciitizen, CimCure, Cimeio Therapeutics, Circle Pharma, Cirqle Biomedical, Citius Pharmaceuticals, City College of New York, City of Hope, Clarus Therapeutics, Clavius Pharmaceuticals, Clearmind Medicine, Cleave Therapeutics, Clene Nanomedicine, Cleveland Clinic, Climb Bio, Clinton Health Access Initiative, Clover Biopharmaceuticals, CMAB Biopharma, CNAO Foundation, CNS Pharmaceuticals, Coalition for Epidemic Preparedness Innovations, Coave Therapeutics, Cobra Biologics, Codagenix, Codexis, Codiak BioSciences, Coeptis Pharmaceuticals, Coeptis Therapeutics, Cognition Therapeutics, CohBar, Coherus Biosciences, CoImmune, Colorado State University, Columbia University, Columbia University Medical Center, CombiGene, Complix, Compugen, Conduit Pharmaceuticals, ConserV Bioscience, Context Therapeutics, ContraFect, Corbus Pharmaceuticals, Cord Blood Registry, COUR Pharmaceutical, COUR Pharmaceuticals, Covar Pharmaceuticals, Coya Therapeutics, CreaGen Biosciences, Creative Biolabs, Crestone Pharma, Creyon Bio, CRISPR Therapeutics, Crohn's and Colitis Foundation of America, Crown Bioscience, CRT Pioneer Fund, CryoPort, CSIRO, CSL, CSL Behring, CSPC Megalith Biopharmaceutical, CSPC Pharmaceutical Group, CStone Pharmaceuticals, CTMC, Cue Biopharma, Cullinan MICA, Cullinan Oncology, Curacle, Curative Biotechnology, Cure Network Dolby Acceleration Partners, CureVac, Curia, Curigin, Curis, CVC, Cyagen Biosciences, Cyan Bio, Cybin, Cybrexa Therapeutics, Cyclacel Pharmaceuticals, Cyclerion Therapeutics, Cyclica, Cyprumed, Cystic Fibrosis Foundation, Cytea Bio, Cytiva, CytoAgents, Cytocom, Cytokinetics, Cytovance Biologics, Cytovation, CYTOVIA Therapeutics, Cyxone, Daewoong Pharmaceutical, Daiichi Sankyo, Dalton Pharma Services, Dana-Farber Cancer Institute, Danish Cancer Society Research Center, Danuo Science Group, Dare Bioscience, Day One Biopharmaceuticals, Debiopharm, Decibel Therapeutics, Defence Therapeutics, Defense Advanced Research Projects Agency, Defense Threat Reduction Agency, Delix Therapeutics, DelSiTech, DeMelle OncoPharma, Denali Therapeutics, Dendreon, Denovo Biopharma, Department of Defense, Dermira, DeuteRx, Dewpoint Therapeutics, Diaccurate, Diakonos Oncology, Dialectic Therapeutics, Diamond Therapeutics, Dicerna Pharmaceuticals, Diffusion Pharmaceuticals, Digestome Therapeutics, DiNAQOR, DiNonA, DiosCURE Therapeutics, Disc Medicine, Diverchim, Diverse Biotech, Dizal Pharmaceutical, DNX Biopharmaceuticals, Dogma Therapeutics, Dong-A ST, DoubleRainbow Biosciences, Dr. Falk Pharma, Dr. Reddy's Laboratories, Dragonfly Therapeutics, DualityBio, Duke-NUS Graduate Medical School Singapore, Duke University, Duke University Medical Center, DxVx, Dyadic International, Dynavax Technologies, DynPort Vaccine Company, DZNE German Center for Neurodegenerative Diseases, Eagle Pharmaceuticals, EA Pharma, Earendil Labs, Ecole Polytechnique de Montreal, Edesa Biotech, Edison Oncology, Editas Medicine, Eikonizo Therapeutics, Eikonoklastes Therapeutics, Eikon Therapeutics, Elanco, Elevar Therapeutics, ElevateBio, ELIAS Animal Health, Elicio Therapeutics, Eligo Bioscience, Eli Lilly, Ellipses Pharma, Elpida Therapeutics, Elpis Biopharmaceuticals, Elpiscience, Elthera, Emergent BioSolutions, Emmaus Life Sciences, Emory University, Enable Injections, ENA Respiratory, Endeavor BioMedicines, Endevica Bio, Enesi Pharma, Enigma Biomedical, Enlivex, Ennaid Therapeutics, Enochian Biosciences, Enosi Therapeutics, Ensem Therapeutics, Ensho Therapeutics, Ensysce Biosciences, Entasis Therapeutics, Enterprise Therapeutics, Entheon Biomedical, Entos Pharmaceuticals, Entrada Therapeutics, Enveric Biosciences, Enzolytics, Enzychem Lifesciences, Enzyvant Science, EOC Pharma, EpicentRx, EpimAb Biotherapeutics, Epivax, EpiVax Therapeutics, Epsilogen, Epygen Biotech, EQRx, Equilibre BioPharmaceuticals, Equillium, Eracal Therapeutics, Erasca, Erasmus University Medical Center, Escugen, EspeRare Foundation, ES Therapeutics, Eterna Therapeutics, Eucure Biopharma, EuMentis Therapeutics, Eunice Kennedy Shriver Institute of Child Health and Human Development, Eureka Eurostars, Eureka Therapeutics, Eurocine Vaccines, Eurofins Discovery, European Innovation Council, European Investment Bank, European Union, Eutilogics, Evariste, Evax, Evaxion Biotech, Evelo Biosciences, Everest Medicines, Eversana, Evgen Pharma, Evolve BioSystems, Evommune, Evonik Industries, Evotec, Evox Therapeutics, Ewha Womans University, Exavir Therapeutics, Exelixis, Exeltis, ExonanoRNA, Exopharm, Exothera, Experimental Drug Development Centre, Expesicor, ExpreS2ion Biotechnologies, Exuma Biotech, Eyam Vaccines and Immunotherapeutics, Eyenovia, F-Star Therapeutics, Farmacore Biotechnology, Faron Pharmaceuticals, Federal Ministry of Education and Research (BMBF), Felix Biotechnology, Ferrer, Fibrogen, FibroGenesis, FightMND, Find Therapeutics, First Wave Bio, FivepHusion, Five Prime Therapeutics, Flame Biosciences, Flightpath Biosciences, Florida International University, FluGen, Fondation Cancer, Foresite Capital, Forge Biologics, Forge Therapeutics, Formation Bio, Formosa Pharmaceuticals, Forsyth Institute, Forty Seven, Fosun Pharmaceutical, Foundation Fighting Blindness, Frazier Healthcare Ventures, French National Blood Service, Frontier Biotech, Fujifilm, FUJIFILM Cellular Dynamics, Fujifilm Diosynth Biotechnologies, Fulgent Pharma, Full-Life Technologies, Fusion Pharmaceuticals, FutureGen Biopharm, G1 Therapeutics, GACI Global, Gaia, Galapagos, Galecto, Galmed Pharmaceuticals, Gannex Pharma, Gastro-Intestinal Research Foundation, GC, GC Cell, GC Pharma, GEMMA Biotherapeutics, Gene by Gene, GeneCraft, Genelux, Genentech, GeneQuantum Healthcare, GeneQuine Biotherapeutics, Generex Biotechnology, Genethon, Genevant Sciences, Genezen, Genfit, Genmab, Gennova Biopharmaceuticals, Genocea Biosciences, GenomeFrontier Therapeutics, Genomma Lab Internacional, Genoscience, Genosera, Genprex, GenScript Biotech, GenScript ProBio, George Mason University, Georgetown University, George Washington University, Giiant Pharma, Gilead Sciences, Ginkgo BioWorks, Glaukos, Global Antibiotic Research and Development Partnership, Global Blood Therapeutics, Global Cancer Technology, Global Coalition for Adaptive Research, Glytherix, GNP Bioscience, Golden Mountain Partners, Goldfinch Bio, Government of Canada, Government of Netherlands, GPCR Therapeutics, Gracell Biotechnologies, Gradalis, Grail, Graphite Bio, Gravitas Therapeutics, Graviton Bioscience, Green Cross LabCell, Greenlight Biosciences, Greenwich LifeSciences, Grey Wolf Therapeutics, Griffith University, GRIT Biotechnology, Gritstone Bio, GSK, GT Biopharma, GTP Bioways, GW Pharmaceuticals, Gyroscope Therapeutics, Hadassah Medical Center, HaemaLogiX, Halozyme Therapeutics, Hamlet Pharma, HanAll Pharmaceuticals, Hande Sciences, Hangzhou Zhongmei Huadong Pharmaceutical, Hansa Biopharma, HanX Biopharmaceuticals, Harbour Biomed, Harmony Biosciences, Harvard Medical School, Harvard University, Havn Life Sciences, HAYA Therapeutics, HBM Alpha Therapeutics, HCW Biologics, HDT Bio, Healion Bio, Healis Therapeutics, Health Holland, Heartseed, Hebrew University of Jerusalem, Heidelberg Pharma, HekaBio, Hemera Biosciences, Hemogenyx, Henlius Biotech, Henry M. Jackson Foundation, HepaTx, Herantis, HiberCell, HiFiBio, HilleVax, Hillstream BioPharma, Hinge Bio, Histogen, Hisun BioRay, HitGen, HK inno.N, Hoffmann La Roche, Horama, Horizon Therapeutics, Hoth Therapeutics, Huadong Medicine, Hualan Genetic, Humanetics, Hummingbird Bioscience, Hutchmed, Huyabio International, HUYA Bioscience, Hybridize Therapeutics, Hygtia Therapeutics, Hyloris Pharmaceuticals, Hypersomnia Foundation, IACTA Pharmaceuticals, IAMA Therapeutics, Iaso Therapeutics, iBio, Icahn School of Medicine at Mount Sinai, IcanoMAB, Ichnos Sciences, Ichor Medical Systems, Iconovo, IDEAYA Biosciences, Idorsia, IGAN Biosciences, IGM Biosciences, Igyxos, Ikarovec, Iksuda Therapeutics, Iktos, Ildong Pharmaceutical, Imcyse, Imeka, IMIDomics, Immatics Biotechnologies, Immune Biosolutions, ImmuneOncia Therapeutics, Immune System Regulation, Immune Therapeutics, ImmuNext, ImmunityBio, ImmunoFlex, ImmunoGen, ImmunoGenesis, Immunome, Immunomic Therapeutics, ImmunoPrecise Antibodies, ImmunoScape, Immuron, Immutep, IMMvention Therapeutix, ImmVira, IMPACT Therapeutics, IMP Clinical Supply Services, Imperial College London, ImQuest BioSciences, Imugene, Imunon, In4Derm, Incannex Healthcare, Inceptor Bio, Incyte, Indapta Therapeutics, Indiana University, Indian Institute of Science Education and Research, Indivior, InduPro Therapeutics, Infectious Disease Research Institute (IDRI), Infex Therapeutics, Infinimmune, Inhalation Sciences, Inhalon Biopharma, Inhibikase Therapeutics, Inhibrx, Inimmune, Inmagene Biopharmaceuticals, InMed Pharmaceuticals, INmune Bio, Innovate UK, Innovation Norway, Innovation Pharmaceuticals, Innovent Biologics, Inotrem, Inovio Pharmaceuticals, Inozyme Pharma, InSightec, Insilico Medicine, InSilicoTrials, Insitro, Institut Curie, Institute for Life Changing Medicines, Institute for Research in Immunology and Cancer – Commercialization of Research, Institut Gustave Roussy, Institut Pasteur, Intec Pharma, Integral Molecular, Intellia Therapeutics, InterAx Biotech, Interius BioTherapeutics, Intravacc, Intrommune Therapeutics, iNtRON Biotechnology, IntuitiveX, Inventiva, Inventprise, Invetx, invIOs, iOncologi, iOnctura, Ionetix, Ionis Pharmaceuticals, Iovance Biotherapeutics, IOVaxis Therapeutics, ipCapital Group, I Peace, Ipsen, IQVIA, Ironwood Pharmaceuticals, ISD Immunotech, Isofol Medical, Isoprene Pharmaceuticals, IsoTherapeutics, Israeli National Authority for Technological Innovation, Israel Institute for Biological Research, Istari Oncology, Italfarmaco, ITM Isotopen Technologien, iTolerance, Ivy Brain Tumor Center, Ixaka, Ix Therapeutics, J-STAR Research, Jackson Laboratory, JanOne, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Jasper Therapeutics, Javelin Biotech, Jazz Pharmaceuticals, JCR Pharmaceuticals, jCyte, Jefferson Healthcare, Jellagen, Jemincare, Jenga Biosciences, Jenner Institute, Jiangsu Chia Tai Fenghai Pharmaceutical, Jiangsu Chia Tai Tianqing Pharmaceutical, Jiangsu Hansoh Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, Jiangsu NHWA Pharmaceutical, Jiangsu QYuns Therapeutics, JiKang Therapeutics, J Ints Bio, Ji Xing Pharmaceuticals, Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Innovation, Joincare Pharmaceutical, Jorna Therapeutics, Jounce Therapeutics, Joyo Pharmatech, Jubilant Radiopharma, Jubilant Therapeutics, Juniper Biologics, Junshi Biosciences, Juntendo University, Juri Biosciences, Juvena Therapeutics, Juvenile Diabetes Research Foundation, JW Therapeutics, Kadimastem, KAHR Medical, Kaigene, Kainos Medicines, Kairos Pharma, Kaken Pharmaceutical, KaliVir Immunotherapeutics, Kamada, Kanaph Therapeutics, KangWon University Institute of Medical Science, Kanyr Pharma, Karolinska Institute, Karolinska University Hospital, Karuna Therapeutics, Kashiv BioSciences, Kate Therapeutics, Kazia Therapeutics, KBI BioPharma, Keck School of Medicine of USC, Kedrion Biopharma, KeifeRx, Kelai Pharmaceuticals, KemPharm, Kemwell BioPharma, Kennedy Institute of Rheumatology, Kentucky Organ Donor Affiliates, Kenya Medical Research Institute, Khon Kaen University, Kiadis Pharma, Kindred Bio, Kinea Bio, Kineta, Kings College London, Kinnate Biopharma, Kinnear Pharmaceuticals, Kintara Therapeutics, Kintor, Kiora Pharmaceuticals, Kiq, Kiromic Biopharma, Kleo Pharmaceuticals, Kolon Life Science, Konkuk University, Korea Institute of Radiological and Medical Sciences, Kovina Therapeutics, Kriya Therapeutics, Kronos Bio, KSQ Therapeutics, Kubota Vision, Kuria Therapeutics, KWF, KYAN Therapeutics, Kymera Therapeutics, Kyorin Pharmaceutical, Kyowa Hakko Kirin, Kyttaro, Kyverna Therapeutics, LabCentral, Laboratoires Thea, Lactiga, Laekna, Lamassu Pharma, LamKap Bio Group, LaNova Medicines, Lantern Pharma, La Paz Hospital, Launch Therapeutics, Lava Therapeutics, Lawrence Livermore National Laboratory, Leap Therapeutics, Lee's Pharmaceutical, Lee Moffitt Cancer Center, LegoChem Biosciences, Leiden University, Leidos, Lenire Biosciences, LEO Pharma, Lepu Biopharma, Les Laboratoires Servier, Leucid Bio, Leukocare, LeukoCom, Leveragen, LEXEO Therapeutics, Lexicon Pharmaceuticals, LGC, LG Life Sciences, LianBio, Liechti Lab, LifeMax Laboratories, LigaChem Biosciences, Light Chain Bioscience, Lighthouse Pharmaceuticals, LimmaTech Biologics, Lineage Cell Therapeutics, LinKinVax, Lisata Therapeutics, LiteVax, Livzon Mabpharm, Lixte Biotechnology, Lobe Sciences, Lobesity Pharma, Locus Biosciences, Lodo Therapeutics, LogicBio Therapeutics, London School of Medicine and Dentistry, Lonza, Louisiana State University, LSU Health Sciences Center, LTZ Therapeutics, Lucid Psycheceuticals, Luminary Therapeutics, Lundbeck, Lung Biotechnology, Lupagen, Lupus Therapeutics, Luxembourg National Research Fund, LyGenesis, Lynk Pharmaceuticals, Lysogene, Lysosomal Therapeutics, Lytica Therapeutics, Lytix Biopharma, Maastricht University, MabCare Therapeutics, MAB Discovery, Mabwell Bioscience, Macrogenics, Macromoltek, Macrostruct Holding & Consulting, Madrigal Pharmaceuticals, Magenta Therapeutics, MagicMed Industries, MAIA Biotechnology, Maine Medical Center, Makana Therapeutics, Mammoth Biosciences, Manhattan BioSolutions, Mannin Research, MannKind Biopharmaceuticals, Manoira Corporation, Mapp Biopharmaceutical, Marinomed Biotechnologie, Martin Pharmaceuticals, Maruho, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, Massachusetts Institute of Technology, Mateon Therapeutics, MatriSys Bioscience, Max-Planck, Maxcyte, Mayo Clinic, Maze Therapeutics, MC2 Therapeutics, McGill University, McMaster University, McQuade Center for Strategic Research and Development, MD Anderson Cancer Center, MDimune, Meabco, Mebias Discovery, Medicago, Medical College of Wisconsin, Medical Research Council, Medical University of Innsbruck, Medical University of South Carolina, Medical University of Vienna, Medicines Discovery Catapult, MediciNova, MediGene, Medigen Vaccine Biologics, MediLink Therapeutics, MedinCell, Medivir, MedPacto, MedPharm, Medshine Discovery, Medytox, Meitheal Pharmaceuticals, Melior Pharmaceuticals, Melodia Therapeutics, Memo Therapeutics, Menarini, Merck and Co, Merck KGaA, Merck Sharpe & Dohme, Merdury Biopharmaceutical, Merrimack Pharmaceuticals, Mersana Therapeutics, Merus, Mestag Therapeutics, Metaclipse Therapeutics, Metagenomi, MetasTx, ME Therapeutics, MetVital, Michael J Fox Foundation, Michigan State University, Microbion, Microbiotix, MicroCures, MicroQuin, MiMedx, Minaris Regenerative Medicine, MiNA Therapeutics, MindBio Therapeutics, Mind Medicine, Mindset Pharma, MindShift Compounds, Minoryx Therapeutics, Minotaur Therapeutics, miRagen Therapeutics, Miralogx, Mira Pharmaceuticals, Mirati Therapeutics, Mirum Pharmaceuticals, Mission Bio, Mitochon Pharmaceuticals, Mitsubishi Tanabe Pharma, Moderna, ModeX Therapeutics, Modus Therapeutics, Molecular Partners, Moleculin Biotech, Molecure, MOMA Therapeutics, Monopar Therapeutics, Moonlight Bio, Mosanna Therapeutics, Mount Sinai Health System, Mount Sinai Medical Center, mProbe Laboratories, MThera Pharma, MultiOmic Health, Multiple Myeloma Research Foundation, Multitude Therapeutics, Murdoch Childrens Research Institute, Mustang Bio, MyBiotics Pharma, Mycenax Biotech, MycoMedica Life Sciences, myDNA, MyMD Pharmaceuticals, Mymetics, MyoKardia, Myosana Therapeutics, Myovant Sciences, Myricx Bio, Myrtelle, Naason Science, Nanobiotix, Nanoform, Nanomerics, NaNotics, NanoTx Therapeutics, NanoVation Therapeutics, NanoViricides, NantKwest, NASA, Nascent Biotech, National Cancer Center, National Cancer Institute, National Center for Advancing Translational Sciences (NCATS), National Centre for Research and Development, National Comprehensive Cancer Network (NCCN), National Eye Institute, National Heart, Lung and Blood Institute, National Institute for Environmental Health Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Dental and Craniofacial Research (NIDCR), National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of General Medical Sciences, National Institute of Infectious Diseases, National Institute of Neurological Disorders and Stroke, National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Drug Abuse (NIDA), National Institutes of Health, National Jewish Health, National Research Council Canada, National Research Council of Canada, National Resilience, National Science Foundation, National University of Ireland, Galway (NUI Galway), Nationwide Children’s Hospital, Natural Sciences and Engineering Research Council of Canada, Naval Medical Research Center, Navidea Biopharmaceuticals, Navigo Proteins, Navrogen, NAYA Biosciences, Negev Labs, Nektar Therapeutics, Neo Gene Pharm, Neogene Therapeutics, NeoImmuneTech, Neotope, NephroDI Therapeutics, NervGen Pharma, Nerviano Medical Sciences, Nestle Health Science, NeuCen BioMed, NeuCyte, NeuExcell, Neumora Therapeutics, Neuraly, Neuraxpharm, Neurgain Technologies, Neurimmune Therapeutics, Neurix, NeurMedix, Neuro3 Therapeutics, NeuroBo Pharmaceuticals, Neurochase, Neurocrine Biosciences, Neurodon, NeuroLucent, Neurophth Therapeutics, Neuropore Therapies, NewCanna Hub, Newsoara Biopharma, New York University, New Zealand's Foundation for Research, Science and Technology, Nexel, Neximmune, NextCure, NextRNA Therapeutics, Nference, NFL Biosciences, Nicox, NiKang Therapeutics, NIMIUM Therapeutics, NIMML Institute, NImmune Biopharma, Ningbo NewBay Medical Technology, Nkarta Therapeutics, NKGen Biotech, NKMax America, NLC Pharma, Noachis Terra, Nobelpharma, Noema Pharma, Noetik, Nona Biosciences, Norgine, North Carolina State University, Northeastern University, Northern Biologics, NorthShore University HealthSystem, NorthStar Medical Radioisotopes, Northway Biotechpharma, NorthX Biologics, NovaRock Biotherapeutics, Novartis, Novasep, Novavax, NoveCite, Novellus Therapeutics, Novelty Nobility, Novo Nordisk, Novotech, NRG Therapeutics, NRx Pharmaceuticals, Nuance Pharma, Nucleai, Numab, Nurix Therapeutics, NurrOn Pharmaceuticals, Nuvectis Pharma, Nxera Pharma, Nykode Therapeutics, NysnoBio, NYU Langone Medical Center, O2nix Bio, Oak Hill Bio, OBI Pharma, Obsidian Therapeutics, Ocean Biomedical, Ocugen, Oculis, Oculogenex, Odimma Therapeutics, ODx, Ohio State University, Olatec Therapeutics, Oligomerix, OliX Pharmaceuticals, Ollin Biosciences, Ology Bioservices, OMass Therapeutics, Omeros, OmniaBio, Onco-Innovations, OncoArendi Therapeutics, OncoC4, Oncoceutics, Oncoheroes Biosciences, Oncology Pharma, Oncology Venture, Oncolytics Biotech, OncoNano Medicine, Oncosyne, OncoVerity, OncoX BioPharma, Oncternal Therapeutics, OnCusp Therapeutics, OneThree Biotech, ONK Therapeutics, Ono Pharmaceutical, Ontochem, Onward Therapeutics, Ophirex, Opsis Therapeutics, Opthea, Optimeos Life Sciences, Optimi Health, Opus Genetics, Oragenics, Oramed Pharmaceuticals, Oravax Medical, OrbiMed Asia Partners, Organicell Regenerative Medicine, Organon, Orgenesis, ORIC Pharmaceuticals, Orion, Orna Therapeutics, Orphazyme, OrsoBio, Ortho Regenerative Technologies, Oryzon, OSE Immunotherapeutics, Osel, Osivax, Ossianix, Ostentus Therapeutics, Otonomy, Otsuka, Ottawa Hospital Research Institute, Overland ADCT BioPharma, Overland Pharmaceuticals, Ovid Therapeutics, Owkin, Oxford BioMedica, Oxford BioTherapeutics, Oxford Vacmedix, OyaGen, Oyster Point Pharma, Ozette Technologies, Palisade Bio, Palleon Pharmaceuticals, Panacea Biotech, Panbela Therapeutics, Pancryos, Panolos Bioscience, Paracelsus Medical University, Paradigm Therapeutics, Paraza Pharma, Parent Project Muscular Dystrophy, Parkinsons Disease Foundation, Parvus Therapeutics, Passage Bio, Path BioAnalytics, Pathogen and Microbiome Institute, PCI Biotech, PDS Biotechnology, PECET, PENAO, Pepper Bio, PeptiDream, Peptilogics, Peptron, Perelman School of Medicine, PersonGen BioTherapeutics, Perspective Therapeutics, Peter MacCallum Cancer Institute, Pfizer, PharmAbcine, PharmaEngine, PharmaEssentia, Pharmaleads, Pharmanovia, Pharmaron, PharmaTher, Pharmidex, Pharmsynthez, PhaseBio Pharmaceuticals, Pheno Therapeutics, Phico Therapeutics, Phio Pharmaceuticals, Phoenix PharmaLabs, Phost’in Therapeutics, PhotonPharma, Photys Therapeutics, Pieris Pharmaceuticals, Pierre Fabre, PineTree Therapeutics, Pionyr Immunotherapeutics, Planet Biotechnology, Pleco Therapeutics, Plex Pharmaceuticals, Plexxikon, Pluristyx, Plus Therapeutics, POINT Biopharma, Polyphor, PolyPid, Polyrizon, Portage Biotech, Poseida Therapeutics, PostEra, Praetego, Praxis Precision Medicines, Precision BioSciences, Precision Molecular, Precision NanoSystems, Pregene Biopharma, Prelude Therapeutics, Premier Inc, Presage Biosciences, Primary Peptides, Primordial Genetics, Primrose Bio, Princeton University, Priovant Therapeutics, ProBioGen, Procyon Technologies, ProEn Therapeutics, ProGen Co, Prokarium, Prokaryotics, Prometheus Biosciences, Proniras, Propella Therapeutics, Prophase Labs, Protalix BioTherapeutics, Prothelia, Prothena, ProtoKinetix, Psilera, PsyBio Therapeutics, PsychoGenics, Psylo, Pulmatrix, PulmoSIM Therapeutics, Pulthera, Puma Biotechnology, Purdue University, Pure Biologics, Pure MHC, Purisys, Purna Pharmaceuticals, Purnovate, Pyramid Biosciences, Pyxis Oncology, Q-Gen Cell Therapeutics, Q2 Solutions, Q32 Bio, Q BioMed, Qilu Pharmaceutical, Qingdao Primedicine Pharmaceutical, Quadira Biosciences, Qualigen, Quebec Consortium for Drug Discovery, Quebec Government, Queen Mary University of London, Queensland Institute of Medical Research (QIMR), Queensland University of Technology, Quince Therapeutics, Quoin Pharmaceuticals, Quotient, QurAlis, Quratis, Qurient, R4D Biotech, Race Oncology, Radboud University Nijmegen, Radient Technologies, Radiopharm Theranostics, Rafael Pharmaceuticals, Rafarma Pharmaceuticals, Ragon Institute, Rain Oncology, Rakovina Therapeutics, Rakuten Medical, Rallybio, Rani Therapeutics, Rappta Therapeutics, Ratio Therapeutics, Ray Therapeutics, ReAlta Life Sciences, Recce Pharmaceuticals, Recipharm, Recludix Pharma, Recro Pharma, Rectify Pharmaceuticals, Recurrent Respiratory Papillomatosis Foundation, Recursion, RedHill Biopharma, Redwood Bioscience, Redx Pharma, Refana, RefleXion Medical, Refuge Biotechnologies, Rega Institute for Medical Research, Regen BioPharma, Regenerative Care Network, Regenerative Medicine of Latin America, Regeneron Pharmaceuticals, Regional Cancer Institute of Montpellier, Reglagene, Regranion, Regulus Therapeutics, ReiThera, Releviate Therapeutics, Remedium Bio, ReNAgade Therapeutics, Renalys Pharma, ReNeuron, Renew Biopharma, Renibus Therapeutics, Repare Therapeutics, Replicate Bioscience, ReproCell, Repurpose.AI, Rescue Hearing, Resilience, RespireRx Pharmaceuticals, Restoration Biologics, resTORbio, Rett Syndrome Research Trust, Revelar Biotherapeutics, Revive Therapeutics, Revolution Medicines, RevOpsis Therapeutics, Reyon Pharmaceuticals, Rgene, Ribon Therapeutics, Richard King Mellon Foundation, Ridgeback Biotherapeutics, Rigel Pharmaceuticals, Rigenerand, Riparian Pharmaceuticals, Riptide Bioscience, Roche, Rockefeller University, Rocket Pharmaceuticals, RocketVax, Roivant Sciences, RosVivo Therapeutics, Roswell Park Cancer Institute, RQ Biotechnology, RS BioTherapeutics, RTW Investments, Rubedo Life Sciences, Rubic One Health, RubrYc Therapeutics, Rugen Therapeutics, Rumi Scientific, Rumpus Therapeutics, Rutgers University, Ryne Biotechnology, Ryvu Therapeutics, SAB Biotherapeutics, Sable Therapeutics, Sage Therapeutics, Saiba, Saint-Gobain Life Sciences, Sairopa, Salarius Pharmaceuticals, Salipro Biotech, Salk Institute, Samsung Biologics, Samyang Biopharmaceuticals, Sana Biotechnology, Sanacor, SandboxAQ, SanegeneBio, Sanford Burnham Institute, Sangamo Therapeutics, San Gerardo Hospital, Saniona, Sanofi, Sansero Life Sciences, Santen Pharmaceutical, Santhera Pharmaceuticals, Sant Joan de Déu-Barcelona Children’s Hospital, Sapien Biosciences, Sapience Therapeutics, Sapphire Biotech, Sarcomatrix Therapeutics, SarcoMed USA, Sarepta Therapeutics, Sartorius, SATT Conectus Alsace, SATT Nord, Scandinavian Biopharma, Scandion Oncology, Scenic Biotech, Schrodinger, SciClone Pharmaceuticals, SciNeuro Pharmaceuticals, Scintomics, Scipher Medicine, SciSparc, Sciwind Biosciences, Scohia Pharma, Scopus BioPharma, Scorpion Therapeutics, Scottish Enterprise, Scripps Research Institute, Scynexis, Seagen, Seal Rock Therapeutics, Seamless Therapeutics, Seattle Children's Hospital, Seattle Children's Therapeutics, Seattle Genetics, Seelos Therapeutics, Seismic Therapeutic, Selecta Biosciences, SelectImmune Pharma, Selenity Pharmaceuticals, Selexis, SELLAS Life Sciences Group, Sen-Jam Pharmaceutical, Senai Cimatec, Sensei Biotherapeutics, Sensorion, Senti Biosciences, Sentinel Oncology, SeraNovo, Seraph Research Institute, Serina Therapeutics, Sernova, Serum Institute of India, Seven and Eight Biopharmaceuticals, SFJ Pharmaceuticals, Shanghai Ark Biopharmaceutical, Shanghai Institute of Materia Medica, Shanghai Medicilon, Shanghai Pharmaceuticals Holdings, Shaperon, Shenogen Pharma, Shenzhen Salubris Pharmaceuticals, Shionogi, Shionogi Pharma, Shoreline Biosciences, Shorla Pharma, Shuttle Pharmaceuticals, Sidewinder Therapeutics, Sierra Oncology, SIGA Technologies, Sigilon Therapeutics, Silence Therapeutics, Silexion Therapeutics, Silk Road Therapeutics, Silo Pharma, Simcere Pharmaceuticals, Simcha Therapeutics, Similis Bio, SimonMed Imaging, Sinclair Research, Singapore General Hospital, Sinntaxis, Sino Biopharmaceutical, Sinopia Biosciences, Sinorda Biomedicine, Sinotek-Advocates International Industry Development, Sinovac Biotech, Sirnaomics, SiSaf, SiteOne Therapeutics, Sitryx Therapeutics, SK Biopharmaceuticals, Skive Hospital, Skye Bioscience, Skymount Medical, smartbax, Smart Immune, SN BioScience, Solid Biosciences, Soligenix, Solve GNE, SOM Biotech, Sona Nanotech, Sonnet BioTherapeutics, Sorrento Therapeutics, Sosei, Sosei Heptares, SOTIO, Soufflé Therapeutics, Southern Research Institute, Southwest College of Naturopathic Medicine & Health Sciences, Sovargen, Spanish National Research Council, Spark Therapeutics, SpectronRx, SpectrumX, Spicona, SpikImm, Spinogenix, SpringWorks Therapeutics, Sprint Bioscience, SpyBiotech, St. Jude Children's Research Hospital, Stanford University, StarkAge Therapeutics, Starton Therapeutics, Statens Serum Institute, STCube, Stealth BioTherapeutics, Stella Diagnostics, StemCardia, Stemedica Cell Technologies, Stemline Therapeutics, Sterling Pharmaceutical Services, Stimunity, Stoked Bio, Stoke Therapeutics, Strand Therapeutics, Strategic Innovation Fund, Strykagen, Stuart Therapeutics, Suanfarma, SUDA Pharmaceuticals, Sumitomo Dainippon Pharma, Sumitomo Pharmaceuticals, Sunovion Pharmaceuticals, SunRock Biopharma, Sunshine Biopharma, Surface Oncology, Surrozen, Sutro Biopharma, Suzhou GenHouse, Suzhou Intragrand Pharma, Suzhou Porton Advanced Solutions, Suzhou Ribo Life Science, Suzhou Runxin Biotechnology, Swift Biosciences, Swiss Federal Funding Programme, Swiss Rockets, Sylics Contract Research, Symbiosis, Symvivo, SynAct Pharma, Synaffix, Syncromune, SynDevRx, Syndivia, Synfini, Syngene, Syngene International, Synspira, Synthekine, Synthetic Biologics, Syracuse University, Systems Oncology, T-MAXIMUM Biotech, TAE Life Sciences, TaiGen Biotechnology, Taisho Pharmaceutical, Takara Bio, Takeda Pharmaceutical, Takis Biotech, Talaris Therapeutics, Tallac Therapeutics, Tango Therapeutics, Tantu Therapeutics, Targeted Pharmaceutical, Targovax, Tarsus Pharmaceuticals, Tarveda Therapeutics, Tavotek Biotherapeutics, TAXIS Pharmaceuticals, Taysha Gene Therapies, TB Alliance, TCG Labs Soleil, TeamedOn International, TechnoVax, Tegmine Therapeutics, Tel Aviv Sourasky Medical Center, Telix Pharmaceuticals, Telomir Pharmaceuticals, Tempest Therapeutics, Tempus, Terran Biosciences, Terumo Blood and Cell Technologies, Tessa Therapeutics, Tessera Therapeutics, Tetra Bio-Pharma, Teva Pharmaceutical Industries, Tevogen Bio, Texas A&M University, Texas Lung Injury Institute, TFF Pharmaceuticals, TG Therapeutics, The International AIDS Vaccine Initiative, Themis Bioscience, Therapeutics Incorporated, Therapeutic Solutions International, Therapix Bio, Therapyx, Theratechnologies, Theriva Biologics, Thermo Fisher Scientific, Thirona Bio, ThirtyFiveBio, Thomas Jefferson University, Tianjin CanSino Biotechnology, Tiba Biotech, TILT Biotherapeutics, Tiziana Life Sciences, TNAX Biopharma, Todos Medical, Tome Biosciences, TONIX Pharmaceuticals, Toregem BioPharma, Tornado Therapeutics, Tottori University, TRACON Pharmaceuticals, Transcend Therapeutics, Transgene, Transpire, Transpire Bio, TransThera, TransThera Sciences, Travere Therapeutics, Traverse Biosciences, Treadwell Therapeutics, TreeFrog Therapeutics, Trefoil Therapeutics, Trellis Bioscience, Trestle Biotherapeutics, TrialSpark, Trigone Pharma, TriLink BioTechnologies, Trinity College Dublin, TriSalus Life Sciences, TScan Therapeutics, Tsinghua University, TTC, TTP Group, Tubulis, Tufts University, Tulane University, Turning Point Therapeutics, Turnstone Biologics, Turn Therapeutics, Tvardi Therapeutics, Twist Bioscience, TYG Oncology, Ubiquigent, Ubix Therapeutics, UCB, UgeneX Therapeutics, UK Government, Umoja Biopharma, Undisclosed Company, UniQure, United Therapeutics, Univercells, University College London, University Gottingen, University Health Network, University Hospital Bonn, University of Adelaide, University of Alberta, University of Antwerp, University of Arizona, University of Bath, University of Bonn, University of British Columbia, University of Calgary, University of California, Davis, University of California, San Diego (UCSD) School of Medicine, University of California Berkeley, University of California Los Angeles, University of California Riverside, University of California San Francisco, University of Campinas, University of Colorado, University of Connecticut, University of Edinburgh, University of Florida, University of Georgia, University of Glasgow, University of Hong Kong, University of Kentucky, University of Lausanne, University of Leeds, University of Leipzig, University of Lethbridge, University of Leuven, University of Louisville, University of Maryland, University of Maryland Baltimore, University of Massachusetts, University of Melbourne, University of Miami, University of Miami Miller School of Medicine, University of Michigan, University of Milano-Bicocca, University of Minnesota, University of Missouri, University of Montreal, University of Oklahoma, University of Ottawa, University of Oxford, University of Pennsylvania, University of Pittsburgh, University of Quebec, University of Queensland, University of Rochester, University of Saskatchewan, University of Sheffield, University of Southampton, University of South Australia, University of South Florida, University of Texas Health SCience Center at San Antonio, University of Texas Health Science Center at Tyler, University of Texas Medical Branch, University of Texas Southwestern Medical Center, University of Toronto, University of Twente, University of Virginia, University of Washington, University of Wisconsin, University of Wisconsin-Madison, University of Zaragoza, University of Zurich, Unnatural Products, Unravel Biosciences, Unum Therapeutics, UroGen Pharma, US Army Institute of Surgical Research (USAISR), US Army Medical Research and Material Command, US Army Medical Research Institute of Infectious Diseases, US Government, Usher III, Utrecht University, UT Southwestern Medical Center, UWM Research Foundation, Vaccibody, Vaccizone, Valbiotis, ValenzaBio, Valneva, Valo Therapeutics, Vanderbilt University, Vanqua Bio, Varian Biopharmaceuticals, Variational AI, Variation Biotechnologies, VaxAlta, Vaxart, Vaxess Technologies, VaxNewMo, Vaxxas, VBL Therapeutics, VectorBuilder, Vectura, VelaVigo, Veloxis Pharmaceuticals, VenatoRx, Ventus Therapeutics, Veraxa Biotech, Verdiva Bio, Verge Genomics, VerImmune, Verndari, Versatope Therapeutics, Verseau Therapeutics, Vertex Pharmaceuticals, Verve Therapeutics, Vesalius Therapeutics, ViaCyte, Viamet Pharmaceuticals, Vibalogics, Victoria University, Viewpoint Molecular Targeting, Vigene Biosciences, ViGeneron, Vincera Pharma, ViralClear Pharmaceuticals, Viralgen, Vir Biotechnology, Virginia Catalyst, Virginia Commonwealth University, Virios Therapeutics, Viroclinics Biosciences, Virpax Pharmaceuticals, Visgenx, Vision Institute, Visirna Therapeutics, Visterra, Visus Therapeutics, VitriVax, VivaCell Biotechnology Espana, Vivace Therapeutics, VIVEbiotech, Vivet Therapeutics, Vivtex, Volastra Therapeutics, Voltron Therapeutics, Vor Biopharma, Voronoi, Voxtur, Voyager Therapeutics, VyGen-Bio, VYNE Therapeutics, Wageningen University, Washington University in St Louis, WaVe Lifesciences, Wayfinder Biosciences, Wellcome Trust, Werewolf Therapeutics, Westport Bio, Wigen Biomedicine, William Harvey Research Instutute, Willow Biosciences, WindMIL Therapeutics, Windtree Therapeutics, Wistar Institute, W L Gore, Worldwide Clinical Trials, WPD Pharmaceuticals, WuXi Advanced Therapies, Wuxi Apptec Laboratory Services, WuXi Biologics, Wuxi Shuangliang Biotechnology, Wuxi STA, WuXi XDC, WY Biotech, X-chem, Xbiome, Xencor, Xentria, Xiamen Biotime Biotechnology, XNK Therapeutics, Xoma, Xortx Therapeutics, Xyphos Biosciences, Y-Biologics, Yale Cancer Center, Yale University, Yeda Research and Development Company, Yisheng Biopharma, Yissum Research Development, Ymmunobio, YolTech Therapeutics, YSP Industries, Yufan Biotechnologies, Yuhan Corporation, Yumanity Therapeutics, Zag Bio, Zai Lab, ZAI Laboratory, Zelira Therapeutics, Zenas BioPharma, Zentalis Pharmaceuticals, Zentiva, Zerion Pharma, Zhittya Genesis Medicine, Zhongze Therapeutics, Zumutor Biologics, Zydus Cadila, ZYUS Life Sciences

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.